Guidant Ancure Adverse Event Reporting Is Focus Of DoJ/FDA Probe

Guidant's disclosure of a criminal investigation by the Department of Justice and FDA related to the Ancure abdominal aortic aneurysm endovascular graft comes just one week after the firm highlighted Cook's Zenith AAA device as a key driver of the $3 bil. merger deal

More from Archive

More from Medtech Insight